Fate Therapeutics Inc (FATE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

3535 GENERAL ATOMICS COURT SAN DIEGO, CA 92121

Fate Therapeutics, Inc provides biotechnology services. The company researches and develops therapies to repair and regenerate body tissues with the help of stem cells.

Data based on most recent fiscal year report
Market Cap1.844 Billion Shares Outstanding75.59 Million Avg Volume1.049 Million
1-Yr BETA vs S&P TR1.825 Current Ratio7.53 Quick Ratio7.53
View SEC Filings from FATE instead.

View recent insider trading info

Funds Holding FATE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FATE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

92.1 Thousand total shares from 7 transactions

Exercise Derivative Conversion (M)

75 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WOLCHKO J SCOTT PRESIDENT AND CEO

  • Officer
  • Director
419,969 2020-01-08 7

SHOEMAKER DANIEL D CHIEF SCIENTIFIC OFFICER

  • Officer
143,091 2020-01-08 5

TAHL CINDY GENERAL COUNSEL AND SECRETARY

  • Officer
99,518 2020-01-08 4

VALAMEHR BAHRAM CHIEF DEVELOPMENT OFFICER

  • Officer
86,058 2020-01-08 2

WEYER CHRISTIAN EVP, RESEARCH & DEVELOPMENT

  • Officer
13,760 2019-12-31 0

RASTETTER WILLIAM H

  • Director
0 2019-12-24 1

AGARWAL SHEFALI CHIEF MEDICAL OFFICER

  • Officer
58,276 2019-12-02 2

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
696,378 2019-10-29 0

LEE MICHAEL STEWART

  • Director
0 2019-09-17 1

NASHAT AMIR

  • Director
2,310,432 2019-07-31 9

ENYEDY MARK J CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
488,998 2019-07-01 0

EPSTEIN ROBERT S

  • Director
0 2019-06-12 1

COUGHLIN TIMOTHY P

  • Director
0 2019-05-08 1

MENDLEIN JOHN

  • Director
0 2019-05-08 1

JOOSS KARIN

  • Director
0 2019-05-03 3

ABBOT STEWART CHIEF DEVELOPMENT OFFICER

  • Officer
64,917 2018-05-15 0

MULTANI PRATIK S CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2018-02-08 0

STORGARD CHRIS CHIEF MEDICAL OFFICER

  • Officer
0 2018-01-16 0

FLYNN PETER D EVP, HEAD OF GLOBAL DEV

  • Officer
0 2017-10-13 0

FATE THERAPEUTICS INC CHIEF SCIENTIFIC OFFICER

  • Officer
103,816 2016-01-08 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

SHOEMAKER DANIEL D - Officer CHIEF SCIENTIFIC OFFICER

2020-01-08 A 90,000 a 90,000 143,091.00 direct

VALAMEHR BAHRAM - Officer CHIEF DEVELOPMENT OFFICER

2020-01-08 A 90,000 a 90,000 86,058.00 direct

TAHL CINDY - Officer GENERAL COUNSEL AND SECRETARY

2020-01-08 A 90,000 a 90,000 99,518.00 direct

WOLCHKO J SCOTT - Director - Officer PRESIDENT AND CEO

2020-01-08 A 219,000 a 219,000 419,969.00 direct

SHOEMAKER DANIEL D - Officer CHIEF SCIENTIFIC OFFICER

2020-01-08 S 5,700 $20.70 d 143,091 143,091.00 direct

VALAMEHR BAHRAM - Officer CHIEF DEVELOPMENT OFFICER

2020-01-08 S 5,700 $20.69 d 86,058 86,058.00 direct

TAHL CINDY - Officer GENERAL COUNSEL AND SECRETARY

2020-01-08 S 5,700 $20.72 d 99,518 99,518.00 direct

WOLCHKO J SCOTT - Director - Officer PRESIDENT AND CEO

2020-01-08 A 66,000 a 419,969 419,969.00 direct

SHOEMAKER DANIEL D - Officer CHIEF SCIENTIFIC OFFICER

2020-01-08 A 25,000 a 148,791 143,091.00 direct

VALAMEHR BAHRAM - Officer CHIEF DEVELOPMENT OFFICER

2020-01-08 A 25,000 a 91,758 86,058.00 direct

TAHL CINDY - Officer GENERAL COUNSEL AND SECRETARY

2020-01-08 A 25,000 a 105,218 99,518.00 direct

SHOEMAKER DANIEL D - Officer CHIEF SCIENTIFIC OFFICER

2019-12-30 S 100 $20.34 d 123,791 123,791.00 direct yes

SHOEMAKER DANIEL D - Officer CHIEF SCIENTIFIC OFFICER

2019-12-30 S 24,900 $19.49 d 123,891 123,791.00 direct yes

SHOEMAKER DANIEL D - Officer CHIEF SCIENTIFIC OFFICER

2019-12-30 M 25,000 d 98,800 123,791.00 direct yes

SHOEMAKER DANIEL D - Officer CHIEF SCIENTIFIC OFFICER

2019-12-30 M 25,000 $2.90 a 148,791 123,791.00 direct yes

WOLCHKO J SCOTT - Director - Officer PRESIDENT AND CEO

2019-12-20 M 25,000 d 139,600 353,969.00 direct yes

WOLCHKO J SCOTT - Director - Officer PRESIDENT AND CEO

2019-12-20 M 25,000 $2.70 a 378,969 353,969.00 direct yes

WOLCHKO J SCOTT - Director - Officer PRESIDENT AND CEO

2019-12-20 S 25,000 $20.17 d 353,969 353,969.00 direct yes

WOLCHKO J SCOTT - Director - Officer PRESIDENT AND CEO

2019-12-19 M 25,000 $2.70 a 378,969 353,969.00 direct yes

WOLCHKO J SCOTT - Director - Officer PRESIDENT AND CEO

2019-12-19 M 25,000 d 164,600 353,969.00 direct yes

WOLCHKO J SCOTT - Director - Officer PRESIDENT AND CEO

2019-12-19 S 25,000 $20.08 d 353,969 353,969.00 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments